Long-term overall survival and progression-free survival in idiopathic pulmonary fibrosis treated by pirfenidone or nintedanib or their switch. Real world data from the EMPIRE registry - Vaskova, M; Sterclova, M; Mogukkoc, N (Eur Resp J, 2019)
et al.